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Abstract
Connexin (Cx) proteins and gap junctions support the formation of neuronal
and glial syncytia that are linked to different forms of rhythmic firing and
oscillatory activity in the CNS. In this study, quantitative reverse transcription
polymerase chain reaction (RT-qPCR) was used to profile developmental
expression of two specific Cx proteins, namely glial Cx43 and neuronal Cx36,
in postnatal lumbar spinal cord aged 4, 7, and 14 days. Extracellular electro-
physiology was used to determine the contribution of Cx36 and Cx43 to a
previously described form of 4-aminopyridine (4-AP)-induced 4–12 Hz rhyth-
mic activity within substantia gelatinosa (SG) of rat neonatal dorsal horn
(DH) in vitro. The involvement of Cx36 and Cx43 was probed pharmacologi-
cally using quinine, a specific uncoupler of Cx36 and the mimetic peptide
blocker Gap 26 which targets Cx43. After establishment of 4–12 Hz rhythmic
activity by 4-AP (25 lmol/L), coapplication of quinine (250 lmol/L) reduced
4-AP-induced 4–12 Hz rhythmic activity (P < 0.05). Preincubation of spinal
cord slices with Gap 26 (100 lmol/L), compromised the level of 4-AP-
induced 4–12 Hz rhythmic activity in comparison with control slices preincu-
bated in ACSF alone (P < 0.05). Conversely, the nonselective gap junc-
tion “opener” trimethylamine (TMA) enhanced 4–12 Hz rhythmic behavior
(P < 0.05), further supporting a role for Cx proteins and gap junctions. These
data have defined a physiological role for Cx36 and Cx43 in rhythmic firing
in SG, a key nociceptive processing area of DH. The significance of these data
in the context of pain and Cx proteins as a future analgesic drug target
requires further study.
Introduction
Gap junctions support electrical signaling and permit
rapid intercellular exchange of small molecules including
ions, second messengers, nutrients, and metabolites (Sohl
et al. 2005). Gap junction channels consist of a pair of
hemichannels that connect opposing cells, either neurons
or glia, through connexin (Cx) protein subunits (Theis
et al. 2005). Identification and characterization of a family
of 20 Cx genes has given an improved understanding of
their roles in the immature and adult central nervous sys-
tem (CNS), highlighting diverse functions ranging from
formation of neuron-glial syncytia to facilitation of rhyth-
mic neuronal firing or distributed network synchrony
(Sohl et al. 2004). In spinal cord, expression of neuronal
Cx proteins such as Cx36 and Cx45 (Chapman et al.
2013; Condorelli et al. 2000) and of glial subtypes includ-
ing Cx43 and Cx32 (Rash et al. 2001; Lee et al. 2005) is
established.
The presence of heterogeneous Cx subtypes in spinal cord
dorsal and ventral horn raises the question of their potential
physiological significance and whether gap junction connec-
tivity could influence sensory or motor functions. For the
latter, a role for gap junctions in coordinating and
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generating motoneuron output is proposed, especially in
the immature spinal cord (Kiehn and Tresch 2002) and
mixed chemical–electrical synapses that express, for exam-
ple, Cx36 have been described (Bautista et al. 2014). For
spinal somatosensory systems, attention has focused largely
on the possible contributions of gap junctions to modula-
tion of nociceptive processing or pain facilitation. By virtue
of their ability to facilitate intercellular communication and
spreading excitation, astroglial gap junctions and Cx pro-
teins are implicated in pathological pain, mirror pain, and
mechanisms of central sensitization (Spataro et al. 2004;
Wieseler-Frank et al. 2004). Animal models of inflamma-
tory pain or nerve injury-induced chronic pain indicate a
dynamic plasticity in the function of gap junctions and
expression of Cx proteins that may drive pathological alter-
ations (Wu et al. 2012). Furthermore, gap junction or
hemichannel conductance is not simply a passive phe-
nomenon but is also subject to active modulation by a vari-
ety of endogenous factors including, for example,
proinflammatory molecules (Orellana et al. 2013).
Previously, we characterized a novel form of rhythmic
activity that is manifested within nociceptive circuitry of
neonatal rat substantia gelatinosa (SG) in vitro and is
reliant on the chemical and electrical neurotransmission
(Asghar et al. 2005). Subsequently, we used a 4-amino-
pyridine (4-AP) model of spinal dorsal horn (DH) hyper-
excitability (Ruscheweyh and Sandkuhler 2003) to induce
4–12 Hz network-based rhythmic firing in SG. This
in vitro SG rhythmic behavior possessed some similarities
to patterned activity previously described for DH in vivo
(EblenZajjur and Sandkuhler 1997) which persisted after
spinalization suggesting localization to spinal cord cir-
cuitry (Sandk€uhler et al. 1995). Using this novel 4-AP
model in vitro, we demonstrated attenuation of 4–12 Hz
rhythmic activity by nonspecific neuronal and glial gap
junction uncouplers such as carbenoxolone or neuronal-
specific gap junction drugs such as mefloquine (Chapman
et al. 2009). These data accord with the reported contri-
bution of electrical synapses and gap junctions to the syn-
chronization of 4-AP-induced neuronal network behavior
in cortical regions (Maier et al. 2002).
To date, few studies have attempted to identify a spinal
DH cellular mechanism for gap junction-related changes
in the context of nociception or altered spinal sensory
processing. In this study, we have utilized the 4-AP model
of neonatal rat DH hyperexcitability in vitro in combina-
tion with extracellular single microelectrode recordings
from within substantia gelatinosa (SG) to characterize
more fully the respective contributions of specific Cx pro-
teins, namely Cx43 which is localized to glia (Dermietzel
et al. 2000) and Cx36 which is accepted as neuronal
specific (Teubner et al. 2000). A quantitative reverse tran-
scription polymerase chain reaction (RT-qPCR)
methodology was used initially to determine developmen-
tal expression of both Cx43 and Cx36 across the postnatal
ages 4 days, 7 days, and 14 days in lumbar spinal cord
tissue. In the electrophysiological studies, the putative
contribution of Cx36 was probed using the Cx36-specific
pharmacological drug quinine (Gajda et al. 2005; Srinivas
et al. 2001). In addition, we determined the contribution
of Cx43 using the gap junction blocker mimetic peptide
Gap 26, a novel short-sequence synthetic peptide corre-
sponding to residues 63–75 of Cx43 within the first extra-
cellular loop of Cx43 (Leybaert et al. 2003), on 4-AP-
induced DH hyperexcitability and rhythmicity. Finally, if
the hypothesis that gap junction closure attenuates 4-AP-
induced 4–12 Hz rhythmicity is correct, then conversely
enhanced connectivity through gap junction could aug-
ment this 4-AP-induced excitation. Trimethylamine
(TMA) increases the efficacy of gap junction coupling
possibly through alkalization (Nassiri-Asl et al. 2008) and
is considered as a nonselective gap junction “opener”.
TMA was used to test the effects of pharmacological
enhancement of gap junction-mediated network connec-
tivity on 4-AP-induced activity in SG in vitro.
The overall aims of the study were firstly, to establish a
causal link between an established form of rhythmic activ-
ity in SG and specific Cx subtypes, namely Cx36 and
Cx43, that are known to be expressed in the spinal cord,
and secondly, to demonstrate the potential for active bidi-
rectional modulation of gap junctions channels in SG.
Methods
RT-qPCR
Male Wistar rats across three postnatal age groups 4 days,
7 days, and 14 days were terminally overdosed by inhalation
of isoflurane (Merial, Essex, UK). Extracted segments of L3–
L6 lumbar spinal cord were stored at 80°C. RNA was
extracted from L3 to L6 of the lumbar spinal cord and
reverse transcribed (RT) into cDNA. To detect relevant Cx
gene expression, TaqMan polymerase chain reaction was
then performed using customized primers for selected Cx
proteins normalized to b-actin (Applied Biosystems Ltd.,
Warrington, Cheshire, UK). cDNA samples were detected in
triplicate using a BioRad iQ5 over 40 cycles. Stock MEGA-
Master mix was prepared using 30 lL of Cx probe and 300-
lL qPCR Master-Mix (Promega, Madison, WI) with 18 lL
ofMEGA-Master mix added to 2 lL of DNA sample.
Single microelectrode extracellular
recordings
All animal procedures complied with current UK legisla-
tion as defined in the Animals (Scientific Procedures)
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Act 1986. Spinal cords were extracted from 12-day-old
Wistar rats terminally anesthetized with pentobarbital
(40–50 mg/kg i.p.). After removal of the pia and dura
mater, 350-lm transverse slices were cut from within
L3–L6 using a vibratome (Leica VT1000S, Leica
Microsystems, Germany). Slices were maintained at 37°C
in oxygenated (95% O2 and 5% CO2) artificial cere-
brospinal fluid (ACSF) containing (in mmol/L): 126
NaCl, 2.5 KCl, 1.4 NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 25
NaHC03, and 11 glucose. For electrophysiology, spinal
cord slices were transferred to a Perspex Haas-type inter-
face chamber humidified with Carbogen (95% O2–5%
CO2). All control and drug-containing solutions were
perfused using a gravity perfusion system at a flow rate
of 1–1.5 mL/min.
Recordings were performed using low resistance (~2–
4 MO) ACSF-filled glass microelectrodes micropositioned
under visual guidance into SG at a depth of 5–10 lm.
In spinal cord slices, the SG is clearly visible with light
microscopy, appearing as a distinctive translucent arc
within the superficial DH easily distinguishable from
deep DH laminae. Voltage waveforms (910) were
recorded with an Axoclamp 2A system (Molecular
Devices, Sunnyvale, CA) and further amplified (91000)
with a Neurolog NL106 module (Digitimer, Welwyn
Garden City, UK). Voltage signals were filtered using a
low pass band filter setting of 40 Hz (Neurolog NL125,
Digitimer) and a Humbug device (Digitimer) for 50 Hz
activity. Recordings were digitized at a sampling rate of
5 kHz and captured for further offline analysis using
Spike 2 software (Cambridge Electronic Design, Cam-
bridge, UK). Power spectra were generated using 1 sec
epochs and the amplitude of the peak frequency was
measured to give the power of the oscillation. Power
amplitude (measured as maximum peak height in spec-
tra) and area values (calculated as the “area-under-the-
curve” for two cursors set at 4 and 12 Hz in spectra)
were derived from an average of six consecutive 1 sec
epochs recorded within the interspike interval of large
amplitude field population spiking activity. The sampling
rate was 5 kHz, which divided by the 8192 points in the
fast Fourier transform, provides an overall resolution of
0.6 Hz. Statistical analysis of power amplitude, power
area, and frequency were performed using a Student’s
two-tailed t test for paired or in the case of Gap 26
unpaired data using raw data values. A Kolmogorov–
Smirnov test indicated that the data were consistent with
a normally distributed population. Data values were
expressed as means  standard error of the mean
(SEM). Values of P < 0.05 were considered statistically
significant. All of the stated n values refer to the number
of spinal slices used per experiment taken from a mini-
mum of three animals.
Pharmacology
Drugs were dissolved in ACSF and applied via separate
gravity-fed inlets. All experiments involving 4-AP (Sigma-
Aldrich, Gillingham, Dorset, UK) were carried out using
25 lmol/L which has been previously shown to induce
stable 4–12 Hz rhythmic activity in SG (Chapman et al.
2009). Either the gap junction opener trimethylamine
(50 lmol/L, TMA) (Acros Organics, Thermo Fisher
Scientific, Geel, Belgium) or the selective Cx36 antagonist
quinine (250 lmol/L) (MP Biomedicals Incorporated,
Solon, OH) were then coperfused with 4-AP. For experi-
ments using the Gap 26 mimetic peptide (Val-Cys-Tyr-
Asp-Lys-Ser-Phe-Pro-Ile-Ser-His-Val-Arg), a comparison
was made between the effects of 4-AP on control spinal
cord slices preincubated in ACSF alone and slices prein-
cubated in ACSF containing 100 lmol/L Gap 26 (Alpha
Diagnostic International Inc., Nottingham, UK) for at
least 4 h. During recordings, slices were perfused with
Gap 26 in the continued presence of 4-AP (25 lmol/L).
Results
Cx36 and Cx43 expression in postnatal
lumbar spinal cord
RT-qPCR demonstrated the gene expression of Cx36 and
Cx43 in lumbar spinal cord tissue from rats across three
developmental ages: 4 days, 7 days, and 14 days postnatal.
Relative to actin, the expression levels for Cx43 were
measured as 12.1  0.27 9 103 at P4 (n = 4),
26.3  3.75 9 103 at P7 (n = 7), and 34.9  7.17 9
103 at P14 (n = 5) (Fig. 1A) indicating an apparent ris-
ing trend in Cx43 gene expression across this postnatal
period, although these differences were not statistically
significant (one-way between-groups ANOVA test). For
Cx36, the gene expression levels relative to actin (Fig. 1B)
were measured as 0.8  0.06 9 103 at P4 (n = 5),
2.1  0.52 9 103 at P7 (n = 7), and 1.7  0.27 9 103
at P14 (n = 4). The expression levels for Cx36 apparently
increased between P4 and P7 and then decreased at P14,
a one-way between-groups ANOVA test indicated that
these differences were not statistically significant. These
gene expression data infer the presence of both Cx36 and
Cx43 in postnatal lumbar spinal cord including tissue
age-matched to that used for electrophysiological studies.
4-AP-induced rhythmic network activity in
SG
Prolonged (30–45 min) superfusion of 4-AP (25 lmol/L)
induced a typical and previously reported (Chapman et al.
2009) pattern of increased population spike and 4–12 Hz
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rhythmic activity within SG (Figs. 2, 3). The 4–12 Hz
4-AP-induced activity is characterized by rhythmic low-
amplitude voltage oscillations (<20 lV) arising from
interspike baseline activity and possesses a typical domi-
nant mean peak frequency of 8.0  0.1 Hz (Fig. 2A). This
interspike 4–12 Hz rhythmic activity is distinct from the
large amplitude population spikes that are also induced by
4-AP, but do not possess a rhythmic profile (Fig. 2A). The
quantified parameters of peak power amplitude and the
power area of drug-induced 4–12 Hz rhythmic activity was
significantly different from low-level baseline activity
recorded in control drug-free ACSF (P < 0.05) (Fig. 3).
Enhancing network activity within SG
through pharmacologically increased gap
junctional coupling
To assess whether an increase in intercellular gap
junctional communication would affect 4-AP-induced
4–12 Hz network activity in SG, the gap junction
“opener” TMA (50 lmol/L) was utilized. Rhythmic
activity was induced and recorded initially under condi-
tions of 4-AP (25 lmol/L) alone and then in the pres-
ence of both 4-AP and TMA (n = 6, 45 min).
Comparing ACSF and 4-AP, the mean power amplitude
(expressed as 106V2) rose from a baseline value of
0.81  0.46 to a value of 2.59  1.5 (P < 0.05). The
corresponding baseline value for power area was
2.48  1.25 in ACSF which increased to 9.32  2.5 after
exposure to 4-AP (P < 0.05). Subsequent coapplication
of TMA and 4-AP further increased both quantified
power amplitude and power area parameters of 4–12 Hz
activity. Figure 2 presents a representative recording
from a single spinal cord slice showing the typical aug-
mentation of 4–12 Hz activity by TMA (Fig 2A and B).
The corresponding power spectrum for this exemplar
recording (Fig 2C) shows the characteristic enhancement
of power amplitude and power area induced by
coapplication of 4-AP and TMA. Figure 3 provides a
comparison of quantified data (n = 6) for power ampli-
tude and area in the presence of 4-AP compared to
coapplied 4-AP and TMA. The power amplitude value
rose from 2.59  1.5 in 4-AP alone to 12.17  0.75
(370% increase) in TMA and 4-AP (Fig. 3). The power
area rose from 9.32  2.5 in 4-AP to 41.48  0.75
(345% increase) in TMA and 4-AP (Fig. 3). The
increases in power amplitude and power area within the
4–12 Hz range following coapplication of 4-AP and
TMA were statistically significant (P < 0.05). When
tested against control baseline activity recorded in drug-
free ACSF, TMA did not by itself evoke any measurable
form of rhythmic activity. In the presence of TMA with
4-AP, the dominant activity profile was not significantly
altered and remained within the 4–12 Hz range
(6.00  0.94 Hz in 4-AP alone and 5.03  1.24 Hz with
TMA and 4-AP, P > 0.05). These data indicate that
while TMA cannot alone induce 4–12 Hz rhythmic activ-
ity, it can act to enhance this form of established ongo-
ing 4-AP-induced activity.
4-AP-induced rhythmic activity is partly
dependent on gap junctions that express
Cx36 and Cx45
The Cx36-specific neuronal gap junction uncoupler
quinine (250 lmol/L) was utilized to assess the reliance
of 4-AP-induced 4–12 Hz rhythmic activity on neuronal
gap junctions expressing this Cx subtype. After establish-
ment of 4–12 Hz rhythmic activity by 4-AP (25 lmol/L),
quinine and 4-AP were subsequently coapplied (45 min).
Quinine significantly reduced 4-AP-induced 4–12 Hz
rhythmic activity without affecting the dominant peak
frequency (7.59  0.66 Hz in 4-AP alone 7.81  0.60 Hz
with quinine and 4-AP, P > 0.05). A typical example of
this for activity recorded from a single spinal cord slice is
illustrated in Figure 4.
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To test the direct involvement of astroglial gap junc-
tions expressing Cx43, the highly specific mimetic peptide
Gap 26 was utilized. A comparison was made between the
level of activity induced within SG in spinal cord slices
preincubated in control ACSF and then exposed to 4-AP
(45 min., 25 lmol/L) versus spinal cord slices that were
preincubated with Gap 26 (4 h, 100 lmol/L) prior to
coapplication of 4-AP and Gap 26. Figure 5 presents typi-
cal recordings from within SG in two separate spinal cord
slices obtained under these two different pharmacological
conditions. While 4-AP continued to induce a dominant
4–12 Hz rhythmic activity profile in control (Figure 5 Ai
and Aii) and Gap 26-treated slices (Fig. 5B), the level of
activity was compromised by Gap 26.
Quantified data for the effects of quinine and Gap 26
on 4–12 Hz activity are summarized in Figure 6. During
cosuperfusion of quinine, power amplitude was reduced
from a value of 1.93  0.33 in 4-AP alone to 0.86  0.28
when quinine was coapplied (P < 0.05, n = 5) (Fig. 6A).
Similarly, the quantified power area value was reduced
from 6.29  1.88 in 4-AP to 2.61  0.77 during coappli-
cation of quinine (P < 0.05, n = 5) (Fig. 6A). These data
represent percentage reduction values of 55% and 59%
for power amplitude and area, respectively, by quinine
and indicate that Cx36-expressing neuronal gap junctions
are necessary for the full manifestation of 4-AP-induced
4–12 Hz rhythmic activity in SG. For Gap 26, the mean
power amplitude was 5.7  1.76 and the power area was
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Figure 2. The effects of trimethylamine on 4-AP-induced network-based activity in SG. (Ai) Trace recording during perfusion of 4-AP, (Aii)
1 sec trace from within an interspike interval, (Bi) Trace recording during perfusion of 4-AP and TMA, (Bii) 1 sec trace from within an interspike
interval during TMA. (C) power spectrum of 4–12 Hz range activity in 4-AP and coapplication of TMA and 4-AP.
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Figure 3. Quantification of power spectral data for effects of TMA
on 4-AP-induced 4–12 Hz rhythmic activity in SG. Compared to 4-
AP alone, coapplication of TMA significantly increases power
amplitude and power area parameters of 4–12 Hz rhythmic activity.
(*P < 0.05, comparing 4-AP and 4-AP plus TMA for area;
~P < 0.05, comparing 4-AP and 4-AP plus TMA for amplitude).
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19.6  4.77 in control slices exposed only to 4-AP
(n = 12) (Fig. 6B). In slices preincubated with Gap 26
and then exposed to Gap 26 and 4-AP (n = 19), the
mean power amplitude was 2.51  0.40 and power area
was 10.40  1.48 (Fig. 6B). These values represent a 56%
reduction in power amplitude which is similar to the
reduction caused by quinine and 47% for power area
which is just slightly smaller than the effect of quinine on
the same parameter. Statistical comparison of the magni-
tude of the differences in mean values for power ampli-
tude and power area between the two groups, Gap 26-
treated versus control untreated spinal cord slices, showed
a significant reduction (P < 0.05) for both parameters
under the condition of Gap 26 preincubation. These data
indicate that Cx43-expressing astrocytic gap junctions are
necessary for the full manifestation of 4-AP-induced
4–12 Hz rhythmic activity in SG.
Discussion
Gene expression for both Cx36 and Cx43 in immature rat
spinal cord over the developmental age range of 4–14 days
postnatal was revealed using RT-qPCR. Some clear trends
in gene expression levels emerged for these two Cx protein
subtypes. Cx43 levels apparently increased across the three
age groups tested, P4, P7, and P14, while the levels of Cx36
initially increased and then decreased. In the CNS, Cx43 is
characteristic of astrocytes, meningeal, and ependymal cells
and in adult rat spinal cord specifically, Cx43 is distributed
throughout the dorsal and ventral gray matter with the
highest levels localized to DH SG (Ochalski et al. 1997).
Cx43 was immunohistochemically localized to an asym-
metrically labeled gap junctions between astrocytic pro-
cesses and oligodendrocytes, potentially creating an
extensive gap junction-coupled syncytium for cellular com-
munication. In contrast, Cx36 is principally associated with
neuronal gap junctions distributed throughout the adult
CNS (Condorelli et al. 2000) including the gray matter of
the spinal cord (Rash et al. 2000), thereby potentially pro-
viding a structural network for electrical or metabolic inte-
gration between neurons. In mouse lumbar DH, Cx36 has
been functionally linked to inhibitory interneurons and is
colocalized with the glycinergic interneuronal marker
GlyT-2 but not the GABAergic marker GAD67 (Nakamura
et al. 2015).
In the continued presence of 4-AP, the spinal SG
in vitro manifests 4–12 Hz rhythmic activity (Chapman
et al. 2009). The precise mechanistic origin of this rhyth-
mic activity is unknown but as a K+ channel blocker with
selectivity toward A-currents, 4-AP will likely exert both
pre- and postsynaptic excitatory effects. In rat DH
in vitro, 4-AP excitation is apparently initiated in the
medial superficial DH with subsequent wider propagation
across the DH (Ruscheweyh and Sandkuhler 2005). In
this 4-AP model of 4–12 Hz rhythmic activity, contrasting
pharmacological strategies that either enhanced or
impaired gap junction conductance revealed a role for
Cx-containing electrical synapses, especially Cx36 and
Cx43, in the generation and maintenance of synchronous
firing across a functional syncytium within SG. In the first
instance, the weak base drug TMA which enhances gap
junction connectivity nonselectively by a process of intra-
cellular alkalization was coapplied with 4-AP (Pais et al.
2003). TMA has well-established proepileptic properties
and enhances 4-AP-induced epileptiform activity in cortex
(Medina-Ceja and Ventura-Mejia 2010). Interestingly,
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TMA alone did not induce excitatory activity within SG
but had a significant and strong enhancing effect on
4-AP-induced 4–12 Hz activity. This was quantified as an
increase in the parameters of power amplitude and power
area derived from fast Fourier spectra analysis. These data
suggest the superimposition of an enhanced level of
4-AP-induced interneuronal synchronous excitation via a
TMA-mediated increase of local gap junction coupling
efficacy within SG.
Conversely, pharmacological disruption of gap junc-
tion conductance using nonspecific uncouplers such as
carbenoxolone has been shown to reduce 4-AP-induced
4–12 Hz rhythmic activity (Chapman et al. 2009) in
spinal DH. In this study, more specific pharmacological
tools have been used to causally link Cx36 and Cx43
to expression of 4-AP-induced 4–12 Hz synchronous
activity in SG. The antimalarial drug quinine preferen-
tially reduces currents through gap junctions that incor-
porate Cx36 without substantially affecting the
conductance of gap junctions that express Cx43 or
other Cx subtypes (Srinivas et al. 2001). Quinine has
been used to probe the role of Cx36 in cortical net-
work synchronization and seizure activity (Medina-Ceja
and Ventura-Mejia 2010; Gigout et al. 2006). The func-
tional deficits reported in the Cx36 knockout mice
indicate a physiological relevance for neuronal gap
junctions in the CNS, particularly with respect to gen-
eration of membrane oscillations and synchronous
recruitment of rhythmic firing (Hormuzdi et al. 2001;
Pais et al. 2003). These data show that quinine had a
pronounced and significant attenuating effect on 4-AP-
induced 4–12 Hz activity suggesting that in SG cou-
pling through Cx36-expressing gap junctions is an
essential contributor to this form of rhythmic activity.
A similar attenuating effect on 4–12 Hz activity was
found using the mimetic peptide Gap 26 which is a
very specific blocker of Cx43, one of the principal Cxs
localized to astrocytes. Taken together, these data sup-
port the existence of an electrically and metabolically
coupled functional syncytium distributed across both
the neurons and glia within immature SG that is cap-
able of supporting rhythmic excitatory activity. The
speculative extrapolation of this finding to the mature
rodent spinal SG is justified on the basis of persistent
expression into adulthood of Cx36 and Cx43 (Ochalski
et al. 1997; Condorelli et al. 2000; Nakamura et al.
2015; Rash et al. 2000) as well as several other Cx sub-
types (Chapman et al. 2013; Lee et al. 2005).
The physiological role of such a gap junction network
within SG and its relevance to nociceptive processing
within SG is unknown. However, the concept of gap
junctions functioning simply as passive intercellular con-
duits is no longer tenable given the substantive evidence
that gap junction channel expression and conductance are
modifiable by factors such as neuropeptides, cytokines, or
growth factors (Giaume et al. 2010). Furthermore, it
seems clear that changes in expression or function may be
linked to pathological conditions including neuropathic
pain and chronic pain states (Wu et al. 2012). For exam-
ple, after L5 spinal nerve ligation, astrocytic Cx43 is
upregulated and suppression of spinal Cx43 expression
inhibited injury-induced mechanical hypersensitivity (Xu
et al. 2014). In another study, chronic constriction injury-
induced mechanical allodynia was at least partially ame-
liorated by Gap 26, the Cx43-specific blocker used in this
study (Chen et al. 2014). Cx43 but not Cx36 expression
is reportedly increased in models of chemotherapy-
induced peripheral neuropathy with a shift in Cx43 to a
more phosphorylated state (Robinson and Dougherty
2015; Yoon et al. 2013). Altered spinal expression of Cx43
has also been characterized in models of spinal cord
injury (SCI) and pain (Chen et al. 2012; Huang et al.
2012). In mice with Cx43/Cx30 deletions, thermal hyper-
algesia and mechanical allodynia triggered by SCI were
prevented (Chen et al. 2012). In contrast to the report-
edly increased Cx43 expression under chronic pain condi-
tions, after a peripheral nerve injury, Cx36 expression was
markedly reduced, with the time course of change paral-
leling the emergence of tactile allodynia (Nakamura et al.
2015), and this effect could be mimicked by injection of
Cx36 siRNA to knock down Cx36 expression. Such stud-
ies implicate altered communication via Cx gap junctions
as a potential contributory factor to central sensitization
perhaps, for example, by more widespread or increased
aberrant excitation across a modified functional syn-
cytium.
In conclusion, these electrophysiological data reveal a
role for neuronal Cx36 and astrocytic Cx43 gap junctions
in a form of rhythmic firing in immature SG that can be
induced in vitro by 4-AP. Further studies will be required
to elucidate the functional significance of these data in
the mature nociceptive DH and, in the context of acute
versus chronic pain, the importance of Cx as a future
analgesic drug target.
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